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The tumor-associated antigen GA733 is a cell-surface glycoprotein highly expressed in colorectal carcinomas. In this study, 3
recombinant genes were constructed as follows: GA733 tagged to the ER retention sequence KDEL (GA733K), GA733 fused to
the immunoglobulin Fc fragment (GA733-Fc), and GA733-Fc fused to the ER retention sequence (GA733-FcK). Agrobacterium-
mediated transformation was used to generate transgenic plants expressing recombinant genes. The presence of transgenes
was conﬁrmed by genomic PCR. Western blot, confocal immunoﬂuorescence, and sandwich ELISA showed the expression
of recombinant proteins. The stability, ﬂexibility, and bioactivity of recombinant proteins were analyzed and demonstrated
through N-glycosylation analysis, animal trials, and sera ELISA. Our results suggest that the KDEL retained proteins in ER with
oligomannose glycan structure and enhanced protein accumulation level. The sera of mice immunized with GA733-FcK puriﬁed
from plants contained immunoglobulins which were at least as eﬃcient as the mammalian-derived GA733-Fc at recognizing
human colorectal cancer cell lines. Thus, a plant system can be used to express the KDEL fusion protein with oligomannose
glycosylation, and this protein induces an immune response which is comparable to non-KDEL-tagged, mammalian-derived
proteins.
1.Introduction
Immunization with tumor-associated antigen (TAA) is a
potential approach for cancer treatment and prevention [1].
Cancer vaccines have not been administered to prevent a
tumor from occurring in healthy individuals. Instead, they
have been used to alleviate the suﬀering of patients who are
already combating cancer [2]. GA733 is an epithelial cell
adhesion molecule (EpCAM) that is abundant in colorectal
cancer cells [3]. In addition, GA733 is known to mediate
Ca2+-independent homotypic cell-cell adhesion [4]. It con-
tains an extracellular domain with 2 epidermal growth fac-
tor-(EGF-) like repeats, followed by a cysteine-poor region, a
transmembrane domain, and a short (26 amino acid) cyto-
plasmic tail [5].Theextracellulardomain (ECD) of GA733 is
often used as a target for cancervaccination [6]. Such recom-
binant vaccines developed over the last several decades have
beenexpressedusingmanyavailableheterologousexpression
systems [7]. Plants are a promising expression system that
can eﬃciently produce recombinant proteins in large quan-
tities without pathogenic animal contaminants [8].
Recently, the tumor-associated colorectal cancer antigen
EpCAM (GA733) was expressed in plants, and the recombi-
nant plant-derived antigen induced a humoral immune re-
sponse in BALB/c mice [9]. However, plants are not an
ideal expression system for producing therapeutic proteins
because of the diﬀerences in the N-glycosylation processes
between plants and humans and the low expression level2 Journal of Biomedicine and Biotechnology
[10]. Plant-derived speciﬁc N-glycans contain antigenic
and/or allergenic β(1, 2)-xylose and α(1, 3)-fucose, which
are absent in mammalian glycans [11]. The plant-speciﬁc
glycans lack sialic acid, which may cause instability and a
lower half-life [12]. To avoid the plant-derived speciﬁc
N-glycan structure, we generated an oligomannose glycan
structure by retaining the recombinant protein (GA733 and
GA733-Fc) in the endoplasmic reticulum (ER). Fusion of
GA733 or GA733-Fc to KDEL (the ER retention motif,
Lys-Asp-Glu-Leu) [13] helps retain the protein inside the
ER and at the same time enhances GA733 and GA733-Fc
assembly in plant cells. The antigen-antibody complex may
potentially have properties similar to the parental IgG, such
as enhanced eﬃcacy of vaccination by targeting the vaccine
to antigen-presenting cells (APCs), facilitated puriﬁcation by
the protein-A method, and increased half-life [2, 14–16].
Furthermore, an antigen-antibody chimera was reported to
provide higher expression levels, better yields, and increased
stability in plant expression systems [2, 17].
In the present study, 3 diﬀerent recombinant human
colorectal cancer antigen GA733 genes were expressed
in a tobacco (Nicotiana tabacum) plant expression system:
GA733 fused to the immunoglobulin Fc fragment (GA733-
Fc), GA733-Fc with KDEL (GA733-FcK), and GA733 with
KDEL (GA733K). The stability and functionality of these
colorectal cancer vaccine candidates were conﬁrmed by
western blot analysis and ELISA, respectively. In order to
understand the fusion of Fc to GA733 and its functionality,
the immunogenicity of recombinant GA733-Fc with oligo-
mannose glycosylation was investigated in mice.
2.MaterialsandMethods
2.1. Construction of the Plant Expression Vector. The syn-
thetic DNA sequence encoding GA733 (Gln38-Lys279, Gen-
Bank accession no. AY189981) was modiﬁed by N-ter-
minal extension with a 30-aa plant ER signal peptide
(MATQRRANPSSLHLITVFSLLAAVVSAEVD) from Nico-
tiana plumbaginifolia and C-terminal extension with an ER
retention signal (KDEL). The recombinant chimeric protein
GA733-FcwasgeneratedbyfusingGA733totheFcfragment
of human IgG1 (Val97-Gly328, GenBank accession no.
AY172957).TheLys279(C-terminusofGA733)wasfollowed
by the Val97 (N-terminus of Fc fragment of human IgG1).
The GA733-Fc-encoding sequences were placed under the
control of the enhanced cauliﬂower mosaic virus (CaMV)
35S promoter and tobacco etch viral 5 -leader sequence
(TEV). The GA733, GA733-Fc, and GA733-FcK expression
cassettes were subcloned into the HindIII sites of the
binary plant transformation vector pBIN-Plus to yield pBI
GA733K, pBI GA733-FcK, and PBI GA733-Fc, respectively
(Figure 1(a)).
2.2. Plant Transformation. Recombinant vectors were intro-
duced into the Agrobacterium tumefaciens strain LBA4404
by electroporation. Transgenic tobacco plants were gen-
erated by Agrobacterium-mediated transformation [11].
Transgenic tobacco lines were selected on Murashige and
Skoog medium (Dachfu, Haarlem, Netherland) containing
100mg/L kanamycin. Transgenic plantlets were then trans-
ferred to soil in a growth chamber at a constant temperature
of 23◦C and 70% humidity and were maintained under a
14:10h light-dark cycle. Transgenic and nontransgenic N.
tabacumplantsweregrowninagreenhouseundercontrolled
conditions.
2.3. PCR Ampliﬁcation of Genomic DNA. Genomic DNA
was isolated from the fresh leaf tissue of transgenic and
non-transgenic plants using a DNA extraction kit (iNtRON
Biotechnology, Seoul, Republic of Korea) according to
the manufacturer’s recommendations. PCR ampliﬁcation
of genomic DNA was performed in order to conﬁrm the
presence of the recombinant genes using the following
primer pairs: for GA733K, forward primer 5 -GCG TCG
ACA CGG CGA CTT TGC CGC TCA GGA A-3 ,r e v e r s e
primer 5 -GCT CTA CAT CAG AGT TCA TCT TTT TTT
AGA CCC TCG ATT GAG-3 ; for GA733-FcK, forward
primer 5 -GCG TCG ACA CGG CGA CTT TTG CCG CAG
CTC AGG AA-3 , reverse primer 5 -GCT CTA GAT CAG
AGT TCA TCT TTA CCC GGG GAC AGG G-3 ; for GA733-
Fc, forward primer 5 -GCG TCG ACA CGG CGA CTT
TGC CGC AGC TCA GGA A-3 , reverse primer 5 -GCT
CTA GAT CAA CCC GGG GAC AGG GAG AG-3 .P C R
was performed with 38 cycles of 94◦C for 60s, 55◦Cf o r
60s, and 72◦C for 60s. Non-transgenic plants were used as
negative control, while a T-easy vector (Promega, Madison,
WI, USA) containing the GA733-FcK gene was used as a
positive control. The expected size of the DNA products for
GA733K, GA733-FcK, and GA733-Fc was 768, 1483, and
1471bp, respectively.
2.4. RNA Isolation and Semiquantitative RT-PCR. The tran-
scription levels of GA733K, GA733-FcK, and GA733-Fc
mRNA were quantiﬁed by performing semi-quantitative RT-
PCR. Total RNA was extracted from transgenic and non-
transgenic plants using the RNeasy plant mini kit (Qiagen,
Valencia, CA, USA), according to the manufacturer’s pro-
tocol. To remove the genomic DNA, 600ng of total RNA
was treated using a TURBO DNA-free kit (Ambion, Austin,
TX, USA) in a reaction volume of 20μL. The RNA samples
were stored at −80◦C until use. Each RNA sample was used
as a template for RT reactions performed using AccuPower
RT/PCR PreMix (Bioneer, Daejeon, Republic of Korea). RT-
PCR was performed using the following master mix: 4μL
10× RT-PCR buﬀer, 2μLf o re a c hp r i m e r( 1 0p m o l / μL), 2μL
10mM dNTPs, and 1μL of HotStart Taq DNA polymerase
(Bioneer); the volume of the mix was adjusted to 22μLw i t h
sterilized water, and 3μL of RNA was added as a template.
The following primers were used in the RT-PCR reaction:
for GA733K, forward primer 5 -GCA GCT CAG GAA GAA
TCT-3 , reverse primer 5 -CTC AGA GCA GGT TAT TTC
A-3 ; for GA733-FcK or GA733-Fc, forward primer 5 -ATC
TGG ATC CTG GTC AAA-3 , reverse primer 5 -CTC AGA
GCA GGT TAT TTC A-3 ; for actin (GenBank accession No.
X69885), forward primer 5 -AAT CCA CGA GAC TAC ATA
CAA-3 , reverse primer 5 -AGA GCC TCC AAT CCA GACJournal of Biomedicine and Biotechnology 3
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Figure 1: Schematic diagram of plant expression vectors and recombinant proteins. (a) Gene expression cassettes of GA733K, GA733-FcK,
and GA733-Fc. E/35S-P, the Cauliﬂower mosaic virus 35S promoter with duplicated enhancer region; TEV, untranslated leader sequence
of tobacco etch virus; SP, endoplasmic reticulum signal peptide; KDEL, ER retention signal; 35S-T, terminator of Cauliﬂower mosaic virus
35S gene. (b) Structure of recombinant proteins. (c) N-glycan structures of recombinant proteins GA733K, GA733-FcK, and GA733-Fc.
The symbols of the glycan structures are as follows: N-acetylglucosamine, black square; mannose, white circle; fucose, diamond with a dot
inside; xylose, white triangle.
A-3 . The RNA was subjected to RT-PCR with the following
speciﬁcations: reverse transcription at 50◦C for 30min; an
initial PCR activation step at 95◦C for 15min; 38 cycles of
1min at 94 ◦C, 1min at 55◦C, and 1min at 72◦C; a ﬁnal
extension at 72◦C for 10min. The predicted sizes of the RT-
PCR products for GA733K, GA733-FcK, and GA733-Fc are
348, 534, and 534bp, respectively. The actin gene (214bp) is
used as an endogenous control. The RT-PCR products were
analyzed on 1.0% agarose gel.
2.5.ImmunoblotAnalysis. Inordertoevaluatethestabilityof
GA733K, GA733-FcK, and GA733-Fc, a leaf tissue (100mg)
was homogenized in 1× PBS in the presence or absence
of complete protease inhibitor cocktail (Roche Diagnostics,
Mannheim, Germany). The proteins in the homogenates
were resolved by 12.5% SDS-PAGE and transferred to a
nitrocellulose membrane (Millipore, Billerica, MA, USA).
Membranes were incubated with blocking buﬀer (3% skim
milk (Fluka, Buchs, Switzerland) in PBS plus 0.5% (v/v)
Tween 20). The blots were incubated for 1h 30min at RT
with either mouse anti-EpCAM antibody (R&D systems,
Minneapolis, MN, USA) diluted in blocking buﬀer at 1:500
or mouse anti-human Fcγ conjugated to horseradish per-
oxidase (Jackson ImmunoResearch, West Grove, PA, USA)
diluted in blocking buﬀer at 1:3,000 and then incubated for
1h and 30min at RT with secondary antibody goat anti-
mouse IgG (Animal Genetics, Daejeon, Republic of Korea)
diluted in blocking buﬀer at 1:3,000.
Anti-Fcγ recognizes the Fc portion of GA733-Fc, while anti-
human GA733 antibody detects GA733. Protein bands were
visualized by exposing the membrane to an X-ray ﬁlm
(Fuji, Tokyo, Japan) using a chemiluminescence substrate
(Pierce). Non-transgenic plants and the recombinant human
EpCAM/TROP-1 Fc chimera (R&D systems), of which the
human EpCAM/TROP-1 is fused with the Fc fragment of
human IgG1, were used as negative and positive controls,
respectively.
2.6. Confocal Microscopy Analysis. To reconﬁrm the expres-
sion of recombinant proteins, confocal microscopy analysis
was carried out. The leaf samples were collected from the
3 transgenic plants (GA733K, GA733-FcK, and GA733-Fc)
and a non-transgenic plant and were then ﬁxed in formalin-
acetic acid-alcohol solution for 24h. The ﬁxed leaves were
dehydrated in ethanol, cleared in xylene, and embedded in
paraﬃn blocks. The paraﬃn blocks were sectioned into 7-
μmslicesandattachedtogelatin-coatedslides.Thesectioned
tissues were rehydrated with xylene and ethanol. The tissue
slides were incubated with 1% bovine serum albumin in
0.01M PBS (pH 7.2) to block nonspeciﬁc binding of the
primary antibody. The primary antibodies, mouse anti-
GA733 IgG, and goat anti-human IgG Fc antibody (Animal
Genetics), were diluted 1:500 in PBS and applied to samples
for 3h at RT. The tissue slides were then incubated for
another 3h at RT with the secondary antibodies, Alexa-
488 conjugated anti-mouse IgG (Invitrogen, CA, USA) and4 Journal of Biomedicine and Biotechnology
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Figure 2: PCR analysis of genomic DNA from transgenic plants. Genomic DNA of GA733K (780bp), GA733-FcK (1473bp), and GA733-Fc
(1461bp)transgenicplants.+:positivecontrol,T-easyvectorwithgeneofinterest;NT:negativecontrol,genomicDNAfromnon-transgenic
tobacco plants.
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Figure 3: RT-PCR analysis of recombinant gene expression in transgenic plant. RT-PCR analysis of GA733K (348bp), GA733-FcK (534bp),
and GA733-Fc (534bp). NT: negative control, non-transgenic plant. The actin gene (214bp) was used as an endogenous control.
Alexa-546 conjugated anti-goat IgG (Invitrogen), diluted
1:300 in PBS. In order to stain the nucleus, the slides were
incubated with TO-PRO-3 iodide (Invitrogen). Anti-human
IgG and TO-PRO-3 ﬂuorescence was observed using a
confocallaserscanningmicroscope(Olympus,Tokyo,Japan)
at 488nm and 633nm, respectively.
2.7. Sandwich ELISA. The expression and assembly of vac-
cine candidates in plants were further analyzed by sandwich
ELISA. Brieﬂy, 96-well MaxiSorp surface plates (Nunc,
Rochester, NY, USA) were coated with 1μg/mL mouse anti-
human GA733 antibody in 50mM sodium carbonate (pH
9.6). The leaf tissues (100mg) were homogenized in 200μL
of extraction buﬀer containing 10mM sodium sulfate, 2%
polyvinylpyrrolidone (molecular weight, 40,000kDa), 3mM
sodium azide, and 0.5% Tween 20. Leaf extract samples
were diluted 2-fold in extraction buﬀer, and then serial
3-fold dilutions were made in PBS. Recombinant human
EpCAM/TROP-1 Fc chimera (R&D systems, 5μg/mL) was
used as a positive control, and a rabies antibody (Bethyl,
Montgomery, TX, USA) was used as a negative control.
The plate was incubated with secondary antibody goat anti-
human Fcγ conjugated to horseradish peroxidase (Jackson
ImmunoResearch)(1:3,000)dilutedinPBSfor2hatRTand
was detected using soluble TMB (3.3 ,5 . 5  -tetramethyl-
benzidine) substrate (KPL, Gaithersburg, MD, USA). The
antibody titers in 3 wells per tested sample were estimated
by determining the optical density at 450nm using an ELISA
reader Sunrise (TECAN, M¨ annedorf, Switzerland).
2.8. Isolation and Puriﬁcation of Plant-Derived Recombinant
Chimeric Protein. Isolation and puriﬁcation procedures of
the recombinant proteins were followed as described in
ap r e v i o u ss t u d y[ 18]. Plant leaves were homogenized in
an HR2094 Aluminium Blender (PHILIPS, Seoul, Republic
of Korea) in chilled extraction buﬀer (37.5mM Tris-HCl,
50mM NaCl, 15mM EDTA, 75mM sodium citrate, and
0.2% sodium thiosulfate). After centrifugation for 30min at
15,000×g, the supernatants were further clariﬁed through
a Miracloth (Calbiochem, La Jolla, CA, USA), and solid
ammonium sulfate was added 16% saturation. After 2h
incubation at 4◦C, the solution was centrifuged at 15,000×g
for 30min at 4◦C, the precipitate was discarded, and
ammonium sulfate was added to the supernatant to 40%
saturation. After incubation at 4◦C overnight, the solution
was centrifuged at 15,000×gf o r3 0 m i na t4 ◦C, and the
pellet was resuspended in extraction buﬀer at one-ﬁfth of
the original volume. Soluble protein extract was applied to
a protein A column (GE Healthcare, Piscataway, NJ, USA).
Eluates of plant-derived recombinant GA733-Fc protein
were dialyzed against 1× PBS buﬀer and brought to a ﬁnal
concentration of 1mg/mL using an Amicon Ultra spincol-
umn with a 10kDa cutoﬀ (Millipore). Aliquots were frozen
in liquid nitrogen and stored at −80◦C. For analysis, extractsJournal of Biomedicine and Biotechnology 5
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Figure 4: Western blot of GA733-FcK and GA733-Fc expression. Leaf samples from GA733-FcK and GA733-Fc transgenic plants
were ground with extraction buﬀer containing protease inhibitor (With PI) or not (Without PI) to conﬁrm the stability of proteins.
Soluble proteins were detected by mouse anti-human Fcγ antibody and mouse anti-human GA733 antibody. +: positive control, human
EpCAM/TROP-1 (GA733) Fc chimera.
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Figure 5: Western blot of GA733K and GA733-FcK expression. Leaf samples from GA733K and GA733-FcK transgenic plants were ground
with extraction buﬀer containing protease inhibitor (With PI) or not (Without PI) to conﬁrm the stability of proteins. Soluble proteins were
detected by mouse anti-human Fcγ antibody and mouse anti-human GA733 antibody.
were resolved by SDS-polyacrylamide gel electrophoresis
(PAGE) and either stained or transferred to a nitrocellulose
membrane (Millipore), blocked with 3% nonfat milk and
murine anti-GA733 IgG (Calbiochem, San Diego, CA, USA),
and followed by secondary antimurine mAb conjugated to
horseradish peroxidase (Sigma, St. Louis, MO, USA) diluted
1:10,000 to detect GA733. For Fc detection, the secondary
antimurine IgG conjugated to horseradish peroxidase was
used. Non-transgenic plants and the recombinant human
EpCAM/TROP-1 Fc chimera (R&D systems) were used as
negative and positive controls, respectively. Reactive protein
bands were visualized using the chemiluminescent peroxi-
dase substrate (Pierce).
2.9. N-Glycan Proﬁle Analysis. S a m p l e sw e r eﬁ r s td i g e s t e d
intoglycopeptidesusingpepsin,aspreviouslydescribed[19].
From the resulting glycopeptide mixtures, N-glycans were
released using peptide N-glycosidase (PNGase) A (Roche,
Basel, Switzerland). The released N-glycans were puriﬁed
using graphitized carbon resin from Carbograph (Alltech,
Lexington, MA, USA). Puriﬁed glycans were dried and
then redissolved in a mixture of 90μL dimethyl sulfoxide
(DMSO), 2.7μLw a t e r ,a n d3 5 μL iodomethane for solid
phase permethylation using a spin-column method [20].
After the process previously described, the chloroform layer
containing permethylated glycans was dried and resus-
pended in 4μL of a 50% methanol solution. Then, it was
mixedinequalvolumewiththematrix2,5-dihydroxybenzoic
acid prepared in 1mM sodium acetate solution. The result-
ing mixtures were applied onto an MALDI MSP 96 polished
steel Chip (Bruker Daltonik GmbH, Bremen, Germany) and
dried. Matrix-assisted laser desorption/ionization-time of
ﬂight (MALDI-TOF) mass spectrometry was performed in
the reﬂector positive ion mode using a Microﬂex (Bruker
Daltonik). All mass spectra were acquired at a 20kV
accelerating voltage using the method recommended by the
manufacturer.6 Journal of Biomedicine and Biotechnology
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Figure 6: Confocal immunoﬂuorescence analysis of GA733K, GA733-FcK, and GA733-Fc expressed in transgenic plant cells. The Fc
fragment was detected by Alexa-546 conjugated anti-human IgG (red). GA733 was detected by mouse anti-human GA733 antibody as a
primary antibody and Alexa-488 conjugated anti-mouse IgG (green) as a secondary antibody. The nucleus was stained with TO-PRO-3
(blue).
2.10. Immunological Analysis of Plant-Derived Recombinant
Chimeric Protein. Six-week-old female BALB/c mice were
purchased from Da Mool Science (Daejeon, Republic Korea)
and maintained in a pathogen-free environment. All mice
experiments in this study were approved by the Wonkwang
University Animal Ethics Committee in accordance with the
guidelines of the Korean Council on Animal Care. Eight-
week-old female BALB/c mice (5 per group) were injected
3 times with 1, 5, or 10μg of plant-derived GA733 or
mammalian-derivedGA733(R&Dsystems)inatotalvolume
of 100μL at 2-week intervals. The ﬁrst and second immu-
nizations were given subcutaneously (s.c.) with complete
(Difco, Detroit, MI, USA) and incomplete Freund’s adjuvant
(Thermo Fisher Scientiﬁc, Roskilde, Denmark), respectively;
the third dose was administered intraperitoneally (i.p.)
in saline. Blood samples were collected by retroorbital
bleeding before the experiment and 10 days after the
second immunization; 10 days after the third immunization,
mice were bled individually via the retroorbital plexus and
sacriﬁced. 100μL/well of sera (1μg/mL in PBS) were applied
to ELISA plates coated with human colorectal cells from
lines SW480, SW1116, and SW620, and with human breast
cancer cells from line MCF-7 (4 × 104 cells/well) and
incubated for 2h at RT. 100μL/well secondary antibody
HRP-conjugated goat anti-mouse IgG (Animal genetics)
diluted in PBS (1:8,000) were applied and incubated for 2h
at RT. The signals were detected using soluble TMB (3.3 ,
5.5 -tetramethylbenzidine) substrate (KPL, Gaithersburg,
MD, USA). The results were read by Sunrise (TECAN) at
450nm and presented as mean ± SD.
3. Results
3.1. Generation of Transgenic Plants Expressing GA733K,
GA733-FcK, and GA733-Fc. PCR analysis of the genomic
DNA was performed to conﬁrm the presence of transgeneJournal of Biomedicine and Biotechnology 7
in 10 randomly selected transgenic lines from each type of
vectors among the regenerated plants (Figure 2). The trans-
genic plants lines with GA733K, GA733-FcK, and GA733-Fc
had the expected ampliﬁed bands at 780, 1473, and 1461bp,
respectively. Semi-quantitative RT-PCR analysis was carried
out to conﬁrm mRNA expression in randomly selected
transgenic plants using speciﬁc primers (Figure 3). All tested
GA733K transgenic plants had the band at 384bp, while the
GA733-FcK and GA733-Fc transgenic plants had a band at
534bp. The actin band was detected at 214bp. The ratios of
target gene to actin diﬀered slightly among the transgenic
lines, which suggested that diﬀerent transgenic plants had
diﬀerent expression levels of transgene RNA.
3.2. Eﬀect of the KDEL Sequence on the Expression of GA733-
Fc. Protein extracts from GA733-FcK and GA733-Fc trans-
genic plants were analyzed by western blotting (Figure 4). In
order to conﬁrm the eﬀect of the KDEL sequence on GA733-
Fc expression, leaf tissues were homogenized in 1× PBS buﬀ-
er with or without protease inhibitor (Roche Diagnostics).
Transgenic lines with GA733-FcK (T303 and T305) showed
anapproximately65kDaproteinband,similartothepositive
control; however, this 65kDa band was not detected by
eithertheanti-humanFcγ antibody(Figure4,anti-Fc)orthe
anti-human GA733 antibody with protease inhibitor in the
transgenic lines with GA733-Fc (T103 and T108) (Figure 4,
anti-GA733). In the T303 and T305 protein samples treated
with protease inhibitor (PI), an approximately 140kDa
protein band was detected by the anti-Fc antibody, while in
the T303 protein sample without PI, the 140kDa protein
band was not detected (Figure 4, anti-Fc). In T303 without
PI, the protein bands were generally weaker than in T303
with PI. In both the T303 and T305 samples with PI, the 65
and 140kDa protein bands were detected with the GA733-
speciﬁc antibody; however, no protein bands were observed
in T103 and T108 (Figure 4, anti-GA733). No band was
observed in the non-transgenic plants (data not shown).
3.3. Eﬀect of the Fc Fragment on GA733 Expression. To con-
ﬁrm the expression of the GA733 and GA733-Fc fused to
KDEL, western blot analysis was conducted (Figure 5). In
all the transgenic lines with GA733-FcK (T303, T305, and
T312), an approximately 65kDa band was detected by
the anti-Fc antibody, whereas in the transgenic lines with
GA733K (T202, T203, and T207) no protein band was
detected (Figure 5, Anti-Fc). However, in some of both the
GA733KandGA733-FcKtransgeniclines,the35kDaprotein
band was detected with the anti-GA733 antibody (Figure 5,
anti-GA733). Among all the tested GA733K transgenic lines
treated with or without protease inhibitor, T207 seemed to
have the highest expression. Among all the tested GA733-
FcK transgenic lines, T303 had the highest expression
(Figure 5). In general, the density of the GA733 protein
bands recognized with the anti-GA733 antibody in GA733K
transgenic plants was slightly stronger than that of the
GA733-FcK transgenic plants, indicating that the Fc did not
seem to enhance the GA733 expression level (Figure 5).
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Figure 7: Sandwich ELISA of recombinant proteins. ELISA was
conducted by using 96-well plate coated with mouse anti-human
GA733 antibody. +: positive control, mammalian-derived GA733-
Fc antibody; NT: negative control, non-transgenic plant; mAbM
SO57: human antirabies monoclonal antibody.
3.4. Confocal Immunoﬂuorescence for Conﬁrmation of
GA733K, GA733-FcK, and GA733-Fc Expression in Plant
Cells. Expression of the cancer vaccine candidates GA733K,
GA733-FcK, and GA733-Fc in transgenic plants was
investigated by immunoﬂuorescence staining (Figure 6). In
the analysis, GA733, Fc, and the nucleus were stained in
green, red, and blue, respectively. Green ﬂuorescence activity
was observed in leaf samples from GA733K and GA733-FcK
transgenic plants but not in GA733-Fc plants (Figure 6, anti-
GA733). No red signal was detected in GA733K transgenic
plants. Red ﬂuorescence was detected in leaf samples from
GA733-FcK plants but rarely observed in GA733-Fc plants
(Figure 6, anti-Fc). No green or red signal was detected in
non-transgenic plants.
3.5. ELISA for Conﬁrmation of Recombinant GA733-Fc
Expression. ELISA was conducted to conﬁrm expression of
recombinant GA733-Fc. A 96-well plate was coated with
mouse anti-human GA733 antibody, and soluble plant leaf
protein extracts were applied. Leaf extracts from 2 GA733-
FcK transgenic lines (T303 and T305), 2 GA733-Fc trans-
genic lines (T103 and T108), and a GA733K transgenic
line (T207) were analyzed by ELISA. HRP-conjugated anti-
human IgG Fcγ was used as a secondary antibody to conﬁrm
GA733-Fc expression. Both the T303 and T305 transgenic
lines (GA733-FcK) showed signiﬁcantly greater absorbance
than T103 and T108 (GA733-Fc) (Figure 7). No absorbance
was detected in the transgenic line with GA733K (T207),
which does not have the Fc fragment or with mAbM SO57
(antirabies antibody), which lacks the GA733 fragment. NT
tobacco served as a negative control. A recombinant human
EpCAM/TROP-1 Fc chimera (R&D systems), which is the
positive control, showed high absorbance.
3.6. N-Glycosylation Analysis. The GA733-FcK protein was
puriﬁed from transgenic plants using a protein A aﬃnity col-
umn for glycan structure analysis. However, the GA733-Fc8 Journal of Biomedicine and Biotechnology
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Figure 8: Glycosylation analysis of GA733M-Fcand GA733P-FcK recombinant proteins. The proﬁles of N-glycans released fromGA733M-Fc
and GA733P-FcK were analyzed using MALDI-TOF mass spectrometry after permethylation. The proposed glycan structures for each peak
were designated. GlcNAc, mannose, galactose, and fucose are depicted with black square, white circle, white diamond, and diamond with a
dot inside, respectively.
protein could not be puriﬁed from GA733-Fc transgenic
plants since its expression was very low. GA733M-Fc had
mostly glycan structures with mammalian-speciﬁc α(1, 6)-
fucose residues, whereas GA733P-FcK had oligomannose
glycan structures (Figure 8).
3.7. Immune Response of Mice Injected with Puriﬁed GA733P-
FcK and GA733M-Fc. A GA733-speciﬁc serum IgG antibody
immune response was induced in all mice injected with
puriﬁed GA733P-FcK or GA733M-Fc (Figure 9). The serum
of the injected mice contained IgGs recognizing the human
colorectal cancer cell lines SW480, SW1116, and SW620,
as well as the human breast cancer cell line MCF-7. With
all 3 human colorectal cancer cell lines (SW480, SW1116,
and SW620), serum from mice injected with GA733P-FcK
showed comparable absorbance to serum from mice injected
with GA733M-Fc (Figure 9). With all the colorectal cell
lines, the absorbance rapidly decreased in the serum from
mice injected with GA733M-Fc, whereas the absorbance level
slowly decreased in the serum from mice injected with
GA733P-FcK at dilution factor of 1:50 and 1:100. Mice
injected with 1× PBS did not show any immune response.
Even with the human breast cancer cell line MCF-7, serum
from mice injected with GA733P-FcK showed comparable
absorbance to serum from mice injected with GA733M-Fc.
4. Discussion
Here, we describe the successful expression of chimeric
GA733-Fc, which is a fusion of GA733 to a human IgG Fc
fragment, in plants. In this study, 3 diﬀerent transgenic plant
lines expressing GA733K, GA733-FcK, or GA733-Fc were
established in order to investigate the eﬀect of the Fc frag-
ment and the KDEL retention signal on GA733 expression
and bioactivities. Both PCR and RT-PCR analyses showed
that all randomly tested transgenic plants with each of the
transgenes (GA733K, GA733-FcK, and GA733-Fc) expressed
the transgene transcript. The immunoblot analysis showed
some variation in protein expression. GA733-FcK transgenic
plants had stronger protein expression than GA733-Fc trans-
genic plants, which did not have any detectable protein
expression.TheseresultsindicatethattheERretentionsignal
KDEL stabilized and enhanced GA733-Fc expression. This
higher expression of GA733-FcK can be explained by its
localization in ER [21] and consequently is protected from
proteolytic activity found through the secretary pathway, in
intracellular and extracellular spaces [21, 22]. However, no
signiﬁcant diﬀerences in protein expression were observed
between GA733K and GA733-FcK. Therefore, it seems that
the Fc fragment does not increase GA733 protein expression.
In order to conﬁrm the stability of the GA733-Fc fusion
protein, western blot analysis was performed, and it was
shown that the protein samples homogenized with or
without proteinase inhibitor had similar expression levels,
which indicated that the Fc fusion proteins are stable.
Confocal immunoﬂuorescence analysis reconﬁrmed that
the expression of GA733K and GA733-FcK in plants was
higher than the GA733-Fc expression in plants. In addition,
GA733-FcK transgenic plants expressed GA733 fused to the
human Fc fragment. In the ELISA analysis, the GA733-
FcK transgenic plants (T303 and T305) showed higher
absorbance than the GA733-Fc transgenic plants (T103 and
T108), indicating that the KDEL sequence enhanced GA733-
Fcexpression.TheabsorbancesignalobservedintheGA733-
FcK and GA733-Fc transgenic plants was not detected using
the anti-Fc antibody in the GA733K transgenic plants or
using mAbM SO57, indicating that GA733 is fused to the
Fc fragment and is expressed in GA733-FcK transgenic
plants. The higher yield of GA733-Fc in lines T305 and
T303 and of GA733 with KDEL in lines T202, T203, and
T207 might reﬂect the use of the endoplasmic reticulumJournal of Biomedicine and Biotechnology 9
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Figure 9: Immune response of mice injected with plant-derived GA733-FcK (GA733P-FcK) and mammalian-derived GA733-Fc (GA733M-
Fc, the recombinant human EpCAM/TROP-1 Fc chimera). SW480, SW1116, and SW620 are human colorectal cancer cell lines; MCF-7 is
human breast cancer cell line. X-axis, serum dilution (1/100X); Y-axis, OD 450nm.
retrieval motif KDEL (Lys-Asp-Glu-Leu), which was fused
to the C-terminus of the Fc fragment and/or GA733 in
order to retain the recombinant protein in the endoplasmic
reticulum [11]. We observed lower expression of GA733-
Fc when the KDEL sequence is absent in lines T103, T108,
and T110, which indicates that the endoplasmic reticulum
is a good subcellular location for the accumulation of
recombinant protein. Therefore, in this study, the GA733-
Fc fusion protein did not provide better yield and stability
than GA733 without the Fc fragment fusion. Nevertheless,
the reason that GA733 was fused to the Fc fragment was
the obvious advantage of an easy one-step puriﬁcation
procedure using the protein A method [17, 23]. As a source
ofrecombinantGA733-Fcantigen,solubleFcfusionproteins
have become valuable reagents for immunotherapy and
laboratory investigations. Furthermore, the immunoadhesin
a n t i b o d y - l i k ep r o t e i nd e s i g nr e s u l t e di ns o l u b l ep r o t e i n
accumulation in plant tissues.
GA733-Fc could not be puriﬁed from transgenic plants
since the expression was very low. However, the soluble
GA733-FcKproteinwassuccessfullypuriﬁedusingaprotein-
Aa ﬃnity column for glycan structure analysis and in
vivo animal immunizations. In the glycosylation analysis,
GA733M-Fc had mostly glycan structures with mammalian-
speciﬁc α(1, 6)-fucose residues, whereas GA733P-FcK had
high-mannose glycan structures. These results indicate that10 Journal of Biomedicine and Biotechnology
the KDEL ER retention signal eﬃciently retained the glyco-
proteins, yielding proteins with high mannose [11].
In BALB/c mice, the immune response to GA733P-
FcK appeared to be slightly stronger than that of an equal
dose of GA733M-Fc. It seems likely that this diﬀerential
immunoreactivity is due to the diﬀerent glycosylation pat-
terns in GA733P-FcK and GA733M-Fc. The reactivity of anti-
GA733P-FcK sera with all 3 tested human colorectal cancer
cell lines (SW480, SW1116, and SW620) appeared to be
slightly higher than that of GA733M-Fc sera at sera dilutions
of 1:50 and 1:100 (Figure 9). The reactivity of both anti-
GA733P-FcK and anti-GA733M- F cs e r aw a sm u c hw e a k e r
with the human breast cancer cell line MCF-7 than with
the human colorectal cancer cell lines (Figure 9). However,
a similar trend in diﬀerential immunoreactivity between
GA733P-FcK and GA733M-Fc was also observed at sera
dilutions of 1:50 and 1:100 with the human breast cancer
celllineMCF-7.TheseresultsindicatethatGA733P-FcKwith
high mannose has immunogenicity comparable to GA733M-
Fc.Theantigen-antibodycomplexcanenhancetheeﬃciency
and eﬀectiveness of vaccination by targeting the vaccine
to APCs. It has not been reported that the common Fc-
receptors on mouse APC do interact eﬃciently with human
IgG1 Fc However, in our unpublished data, the human Fc
of a full size human monoclonal antibody has interaction
with the mouse Fc receptor (CD64). Thus, it is speculated
that the human Fc fragment should be speciﬁc for CD64
located on the surface of dendritic cells, which is a known
entry portal to the antigen-processing pathway in mice. The
Fc fragment is speciﬁc for CD64 located on the surface of
dendritic cells, which is a known entry portal to the antigen-
processing pathway. In model systems, the antigen delivered
byantibodyhasbeenshowntobeprocessedandpresentedby
dendritic cells at least 100- to 1000-fold more eﬃciently than
nontargeted antigen [14]. In addition, the oligomannose-
type N-glycan structure would be expected to cause an
enhanced immune response through the mannose receptor
(MR) on macrophages and dendritic cells recognizing the
oligomannose of GA733-FcK [24]. According to a previous
study [11], the ER-type glycans on glycoprotein which are
also known as oligomannose glycan-type can render the
glycoprotein more immunogenic, producing IgG against the
oligomannose glycosylated protein itself.
5. Conclusion
In this study, the data clearly demonstrate expression of
the colorectal cancer vaccine candidate GA733 and the
antigen-antibody complex protein GA733-Fc in tobacco
plant expression systems. Fusion of the Fc fragment of
humanIgGtotheC-terminusofGA733andtheERretention
KDEL in GA733-FcK generating oligomannose glycosylated
proteins is an ideal strategy to easily purify recombinant
GA733 vaccine candidate proteins and to enhance accu-
mulation of the recombinant proteins with oligomannose
for comparable immunogenicity to the non-KDEL-tagged
mammalian-derived proteins in a plant expression system.
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